Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers

Expert Review of Anticancer Therapy

Volumn 13, Issue 1, 2013, Pages 21-27

  Pellegrino, Loredana ^a   Jacob, Jimmy ^a   Roca Alonso, Laura ^a   Krell, Jonathan ^a   Castellano, Leandro ^a   Frampton, Adam E ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dicer; melanoma; microRNA; prognostic marker; survival

Indexed keywords

DICER; MICRORNA; RIBONUCLEASE; TRANSCRIPTION FACTOR SOX4;

CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CYTOPLASM; DICER GENE; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; MELANOMA; OVERALL SURVIVAL; PROTEIN FUNCTION; REVIEW; RNA PROCESSING; TRANSCRIPTION REGULATION;

EID: 84871596055     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.150     Document Type: Review

References (36)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233 (2009).
2. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1), 92-105 (2009).
3. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 435(7043), 834-838 (2005).
4. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu. Rev. Med. 60, 167-179 (2009).
5. Davalos V, Esteller M. Rolling the dice to discover the role of DICER in tumorigenesis. Cancer Cell 21(6), 717-719 (2012).
6. Bahubeshi A, Tischkowitz M, Foulkes WD. miRNA processing and human cancer: DICER1 cuts the mustard. Sci. Transl. Med. 3(111), 111ps46 (2011).
7. Huang YW, Liu JC, Deatherage DE et al. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 69(23), 9038-9046 (2009).
8. Pan X, Zhao J, Zhang WN et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc. Natl Acad. Sci. USA 106(10), 3788-3793 (2009).
9. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 69(2), 709-717 (2009).
10. Aaboe M, Birkenkamp-Demtroder K, Wiuf C et al. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 66(7), 3434-3442 (2006).
11. Jafarnejad SM, Wani AA, Martinka M, Li G. Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am. J. Pathol. 177(6), 2741-2752 (2010).
12. Jafarnejad SM, Ardekani GS, Ghaffari M, Martinka M, Li G. Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion. Oncogene doi:10.1038/onc.2012.239 (2012) (Epub ahead of print).
13. Tijsterman M, Plasterk RH. Dicers at RISC; the mechanism of RNAi. Cell 117(1), 1-3 (2004).
14. Su X, Chakravarti D, Cho MS et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467(7318), 986-990 (2010).
15. Martello G, Rosato A, Ferrari F et al. A MicroRNA targeting dicer for metastasis control. Cell 141(7), 1195-1207 (2010).
16. Ma Z, Swede H, Cassarino D, Fleming E, Fire A, Dadras SS. Up-regulated Dicer expression in patients with cutaneous melanoma. PLoS ONE 6(6), e20494 (2011).
17. Dedes KJ, Natrajan R, Lambros MB et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 47(1), 138-150 (2011).
18. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat. Clin. Pract. Urol. 2(8), 416-422 (2005).
19. Place RF, Wang J, Noonan EJ et al. Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol. Ther. Nucleic Acids 1, e15 (2012).
20. Davis ME, Zuckerman JE, Choi CH et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464(7291), 1067-1070 (2010).
21. Karube Y, Tanaka H, Osada H et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96(2), 111-115 (2005).
22. Merritt WM, Lin YG, Han LY et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359(25), 2641-2650 (2008).
23. Wu JF, Shen W, Liu NZ et al. Down-regulation of Dicer in hepatocellular carcinoma. Med. Oncol. 28(3), 804-809 (2011).
24. Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur. J. Cancer 47(9), 1414-1419 (2011).
25. Stratmann J, Wang CJ, Gnosa S et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 11, 345 (2011).
26. Papachristou DJ, Korpetinou A, Giannopoulou E et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch. 459(4), 431-440 (2011).
27. Faggad A, Kasajima A, Weichert W et al. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology doi:10.1111/j.1365-2559.2011.04110.x (2012) (Epub ahead of print).
28. Grelier G, Voirin N, Ay AS et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br. J. Cancer 101(4), 673-683 (2009).
29. Yan M, Huang HY, Wang T et al. Dysregulated expression of dicer and drosha in breast cancer. Pathol. Oncol. Res. 18(2), 343-348 (2012).
30. Khoshnaw SM, Rakha EA, Abdel-Fatah TM et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Res. Treat. 135(2), 403-413 (2012).
31. Martin MG, Payton JE, Link DC. Dicer and outcomes in patients with acute myeloid leukemia (AML). Leuk. Res. 33(8), e127 (2009).
32. Zhu DX, Fan L, Lu RN et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci. 103(5), 875-881 (2012).
33. Zighelboim I, Reinhart AJ, Gao F et al. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma. Cancer 117(7), 1446-1453 (2011).
34. Flavin RJ, Smyth PC, Finn SP et al. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod. Pathol. 21(6), 676-684 (2008).
35. Chiosea S, Jelezcova E, Chandran U et al. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169(5), 1812-1820 (2006).
36. Tchernitsa O, Kasajima A, Schäfer R et al. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J. Pathol. 222(3), 310-319 (2010).